课题基金 / 基金详情

Behavioral and biochemical effects of schizophrenomimetic drugs, phencyclidine and methamphetamine, in the rat

Behavioral and biochemical effects of schizophrenomimetic drugs, phencyclidine and methamphetamine, in the rat
精神分裂拟态药物苯环己哌啶和甲基苯丙胺对大鼠的行为和生化影响
批准号:
02670527
负责人:
NISHIKAWA Toru
金额:
$1.47万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1990
资助国家:
日本
项目状态:
已结题
起止时间:
1990 至 1991

项目摘要

项目成果

NISHIKAWA Toru的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In order to get further insights into the pathophysiology and the possible pharmacotherapy of schizophrenia, behavioral and biochemical effets of schizophrenominetic drugs, phencyclidine (PCP) and methamphetamine (MAP), have been investigated in the rat. Systemic administration of PCP, which is a non-competitive antagonist of N-sethyl-D-aspartate (NMDA) receptor, incresed dopamine (DA) metabolism in the frontal cortex in a NMDA-reversible manner. with little influence on that in the striatum. Similar results were obtained when selective non-competitive (given systemically) and competitive (given locally into the frontal cortex) antagonists were administered. Intra-cerebroventricular application of D-alanine and D-serine (which are selective allosteric agonists for NMDA receptor) antagonized the PCP-induced hyperactivity, stereotypy and ataxia, and the MAP-induced locomotor stimulation. Systemic administration of PCP and MAP caused differential patterns of c-Fos-like immunoreactivity in … More the brain slices, suggesting the diffences in neuronal circuits activated by the two drugs. Finally, it is demonstrated by gas chromatography (GC), GC-mass spectrometry and high-performance liquid chromatography with fluorometric detection that the brain tissues of rats from neonatal to aged periods contain considerable amount of free D-serine whereas the D-amino acid in the blood samples is present only in trace level. The present study indicates that PCP may elicit hyperdopaminergic activity and abnormal behaviors by, at least in part, blockade of NMDA receptor-mediated neurotransmission. It is also suggested that NMDA receptor sight be involved in hyperlocomotion caused by MAP. These findings add a further support to the hypothesis that reduced excitatory amino acidergic transmission could be implicated in the pathophysiology of schizophrenia. In this aspect, it is of interest to investigate the functional roles of endogenous D-serine and the possile anti-psychotic properties of allosteric agonists of NMDA receptor. Less
期刊论文(63)
专著(0)
科研奖励(0)
会议论文
Tanii Y, Nishikawa T, Hashimoto A and Takahashi K: "Stereoselective inhibition by D- and L-alanine of phencyclidine-induced locomotor stimulation in the rat." Brain Research. 563. 281-284 (1991)
Tanii Y、Nishikawa T、Hashimoto A 和 Takahashi K:“D- 和 L-丙氨酸对苯环己哌啶诱导的大鼠运动刺激的立体选择性抑制。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hashimoto A, Nishikawa T, Hayashi T, Fujii N, Harada K, Oka T and Takahashi K: "The presence of free D-serine in rat brain." FEBS Letters. 296. 33-36 (1992)
Hashimoto A、Nishikawa T、Hayashi T、Fujii N、Harada K、Oka T 和 Takahashi K:“大鼠大脑中存在游离 D-丝氨酸。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hashimoto,A.et al.: "D-Alanine inhibits methamphetamine-induced hyperactivihy in rats" European Journal of Pharmacology. 202. 105-107 (1991)
Hashimoto,A.et al.:“D-丙氨酸抑制甲基苯丙胺诱导的大鼠过度活跃”欧洲药理学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
谷井 靖之ほか: "精神分裂病の病態モデルーその2フェンサイクリジノモデルー" 臨床精神医学. 20. 1499-1510 (1991)
Yasuyuki Tanii 等人:“精神分裂症的病理模型 - 第 2 部分 Phencyclizino 模型”《临床精神病学》20. 1499-1510 (1991)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
57
    Studies on the development of novel pharmacotherapy for schizophrenia that regulates the glutamate receptors
    • 批准号:
      21390330
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.48万
    • 财政年份:
      2009
    • 负责人:
      NISHIKAWA Toru
    • 依托单位:
    Studies on the development of glutamate system-targeted novel pharmacotherapy for schizophrenia
    • 批准号:
      19390302
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.98万
    • 财政年份:
      2007
    • 负责人:
      NISHIKAWA Toru
    • 依托单位:
    Elucidation of molecular pathomechanisms of schizophrenia
    • 批准号:
      17025016
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $68.22万
    • 财政年份:
      2005
    • 负责人:
      NISHIKAWA Toru
    • 依托单位:
    A neurodevelopmental pharmacological approach to the molecular pathophysiology of schizophrenic symptoms
    • 批准号:
      14207040
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $32.2万
    • 财政年份:
      2002
    • 负责人:
      NISHIKAWA Toru
    • 依托单位:
    海外基金